March 19, 2014

Back in the Chemo Chair Again

Yesterday I had one of my periodic CT scans and got the results from my oncologist today. It's been almost 11 months since my last chemotherapy in April, 2013. Before going to see doctor, I reviewed my old CT or CT/PET reports and found that pemetrexed had generally decreased tumor size slowly while I was receiving it, which led me to think it was time to begin again. The latest report showed continued, slow increase in size, and there was an indication that the cancer in the area of the diaphragm has been pushing down on my liver which is not good. \

I have also been concerned about the mutations that are occurring in the tumors. My understanding is that when cells turn cancerous, the proofreading of the DNA when cells divide is damaged so that copying errors, a kind of mutation, become more frequent. I suppose many of these errors may kill the cells before they can grow, but as in evolution, some persist and reproduce. Some of these mutations give the cells the ability to grow and develop into well functioning tumors by acquiring the capacity to develop needed blood vessels to provide food to the cells and the ability to avoid detection by the immune system, for example. If pemetrexed takes out some or most of the cells that are undergoing cell division, then it may be removing some of the cells that are of benefit to the cancerous tissue and harmful to me. Ultimately the cells may acquire the ability to neutralize pemetrexed, but until that time, the drug can help keep the tumor-positive mutations from taking hold.  

Taken all together, my oncologist wanted me to go back on chemo, and I agreed. They arranged for me to get back into a chemo chair in the infusion center today, and I received my first new round of pemetrexed. I'll be getting chemo every three weeks now and will continue until it stops working, or until there are better options available (for example, a drug that unmasks cancer cells so the immune system can find and kill them). 

Luckily, the side effects of pemetrexed are not horrible, mostly a few days of fatigue, but it is something of an inconvenience and limits our flexibility.


What It's Like in the Chemo Chair

I'm not sure I've ever written about the process of getting pemetrexed, so I thought I'd write a description today in case anyone would find it interesting.

After checking in at the desk, I go to the waiting area while I wait my turn. They have a good selection of donated magazine there, and look for something interesting to read. Then an assistant comes in and takes me back to my chair. The chairs are like large recliners, and are in cubicles separated by walls or curtains and face a wall of windows that look out on the hospital and the mountains beyond. The cubicle has chairs for visitors, a table, a TV, and more magazines.

Then the nurse comes in and we begin. She (always been a woman) verifies my identity and ask questions about my current health that she enters into a computer on a rolling stand. They have to calculate how much pemetrexed I need based on my weight and height, and today I had to have my height measured for this year, and it has to be witnessed by two people.

She then accesses the port in my chest and attaches it to a bag of saline, and she also attaches a bag of Kytril, an anti-nausea drug, that infuses for ten minutes.  In the meantime, the oncology pharmacy is preparing my pemetrexed infusion based on my weight and height. When it is ready, she returns with the drug which is shrouded in a brown plastic bag, and with another nurse they verify who I am, what my patient number is, and what medicine I'm getting. Then the infusion begins and lasts for 10 minutes. She deactivates my port, and I am ready to go.

Most of the time is taken up sitting in the waiting room and waiting for my pemetrexed to formulated. I sit back in the recliner, and I always find something to read. Today I found a copy of Science magazine in the room and had the pleasant surprise of reading an article about the domestication of the dog that quoted Greger Larson, the son of our friends Roger and Jane Larson.

I don't typically like to drive after chemo (even though it does not seem to have any affect on me), so Jana goes shopping while I'm in the chair. Today we went to Schlotzky's for one of their good sandwiches on the way home.

February 6, 2014

The Cancer Chronicles

I've got a good book to recommend. When science writer George Johnson's wife was diagnosed with cancer he began a detailed study of the disease. His book "The Cancer Chronicles" uses his wife's diagnosis and treatment as a framework for describing what he learned. As we age, cancer seems to enter more and more of our lives, so if you'd like to know more about the disease, I highly recommend this book. Johnson and a great explainer.

http://www.amazon.com/Cancer-Chronicles-Unlocking-Medicines-Deepest/dp/0307595145/ref=sr_1_1?s=books&ie=UTF8&qid=1391718820&sr=1-1&keywords=cancer+chronicles

October 28, 2013

Asbestos Facts

Last Friday was Mesothelioma Awareness Day, and I have been asked by the Mesothelioma Cancer Alliance ( www.mesothelioma.com) to share some facts about asbestos, the cause of mesothelioma.  I can's say that I support a complete ban of asbestos, but its use should be limited to those that are safe and for which there is no better product. Interestingly, my oncologist says that because there is no heavy industry in Denver that uses asbestos, teachers are the occupational group with the highest incidence of mesothelioma here. 




September 18, 2013

September CT Results and Actions



I have been on a chemo break for four months now.  Yesterday I had a CT scan, and today we saw my oncologist.  The scan showed essentially no growth in one area and a small amount in another.  Dr. Camidge recommended not returning to chemo now, and I readily agreed.  We’ll wait three months between CT scans this time instead of the usual two.

That’s the good news for today, but we had a good discussion of the course of my disease, and what follows is a summary for any who might be interested.  No one was expecting mesothelioma in May, 2010 when the surgeon went in to do a thoracoscopic procedure to end the pleural infusion in my right lung.  When they found cancer, I went through a battery of tests to determine if I was a candidate for an extrapleural pneumonectomy—the removal of my lung—which had the potential of providing a cure.  I qualified, and when they went in, they found cancer in the sack around the heart and decided not to remove the lung.  Instead, they removed the lining of the chest cavity, the pleura, and removed as much of the cancer as they could.  One of my surgeons was very experienced with mesothelioma and must have done a very good job of getting out as much of the cancer as possible because I am still alive three years later.

It seems that my tumors are slow growing, not what I had expected from what I had read about the aggressive nature of mesothelioma.  It also appears that the chemo I’ve had has been effective in keeping it in check, but the researcher in me wonders how quickly it would have grown without the chemo given the slow growth during my chemo breaks.  In summary, it appears that relatively early detection, my generally good health, the skill of the surgeons, and the chemotherapy have combined to keep my cancer from growing too rapidly.  When I was diagnosed it was my goal to be in the long tail of the mortality curve (see the article by Stephen Jay Gould to the right), and so far, so good.

I also think psychological stress has played a roll in my cancers.  As far as I can tell there is no clear relationship between stress and cancer, but both of my cancers were detected in times when I was under greater-than-average stress.  My life now is virtually stress free, and our interactions with our daughters and their families and our friends are positive factors in our lives, so I think my body is better able to deal with the cancer and keep the spread low, especially since there has been no evidence on metastasis.  Thanks to all of you who read this blog for your support as well.

July 17, 2013

Good Cancer News

Jana and I both had visits with our oncologists today.  I have been on a two-month chemo break and had a CT yesterday to see what changes have occurred.  My scan was essentially unchanged from two months ago, so my doctor is happy with letting me extend my chemo break for another two months.

Jana has had periodic (usually every three months) blood tests for cells with the BRC-ABL mutation, the mutation that causes chronic myelogenous leukemia.  The number of cancerous cells dropped rapidly after she started on Gleevec three years ago and has remained at a low level since then.  Recently the concentration has been about 0.001% range.  This time, however, no cells were detected at all.  It doesn't mean that she's cured, but it does raise the possibility of going off of Gleevec if the cells are still undetectable in three months.  Research has shown that patients can go off of Gleevec for some time with out a problem.  If the cells return, then resuming Gleevec is generally effective in reducing the number again, and if it fails there are two other (apparently more effective) drugs that can be used.

All around, we were very happy with today's appointments.

June 5, 2013

100 Laser Shots to the Eye


I have just about all of the degenerative conditions of the pre-elderly, including glaucoma.  Yesterday I underwent a laser treatment for glaucoma that some of you may find interesting.

First a little background.  Glaucoma is a condition in which the internal pressure of the eye is too high.   Normally, the aqueous humor that fills the spaces in front of and behind the iris drains from the eye through a mesh-like structure called the trabecular network at the same rate it is produced.  With glaucoma, however, the exchange of fluid is out of balance and the internal pressure rises which damages the optic nerve if untreated.  My glaucoma is controlled by the use of two kinds of eye drops, but a relatively new laser treatment has been developed that has the potential to reduce or eliminate the need for drops.

The procedure is called Selective Laser Trabeculoplasty (SLT).  An earlier procedure used an argon laser to blast holes in the trabecular network to allow the fluid to drain, but the destruction it caused limited it to a single use.  The new technique is called “selective” because it only affects some cells in the network.  This laser is tuned so that only cells containing granules of melanin, the pigment that makes skin brown, absorb its energy.  As I understand it, the laser heats the granules and either kills the cells directly or injures them enough that they initiate programmed cell death and self-destruct.  With cell death, substances are released that activate aspects of the immune system that remodel the trabecular network and increase the outflow of aqueous humor.  The procedure can be repeated if necessary.

What is it like to undergo SLT?  First drops are used to constrict the pupil in the eye to be treated.  The drops can cause a headache, but that is generally the only pain associated with the procedure.  When the eye is ready, the patient sits in a chair opposite a chin and forehead rest similar to the ones used for a slit-lamp eye examination.  The doctor shines a low-power red targeting laser into the eye and aims it at the edge of the cornea.  When the beam is in the right position, the doctor fires the laser, and the patient sees a flash of green light.  The doctor moves the targeting beam to another location and fires again for a total of about 100 short that cover the circumference of the cornea.  I found the treatment to be completely painless, and it took perhaps five minutes to make the 100 shots.  I have to use anti-inflammatory eye drops four times a day for four days and go back in two weeks to see if the treatment was a success.   If so, then the other eye will be treated.

I was attracted to SLT because it has the potential to make structural changes to the trabecular network that provide at least a temporary “cure” for the disease.

May 15, 2013

School's Out For the Summer! -- Reprise


Today I got the results of my latest CT scan from my oncologist today.  My tumors remain stable.  In fact, they have not changed meaningfully since I started my latest round of pemetrexed chemotherapy last August.  Now, 12 infusions later, I got down on my knees and begged my doctor to let me take a chemo break.  Pulling out his whip, he yelled, “No and get back in that chair.”

Not really.  He thought it would be fine to take a break and come back for a CT in mid-July to see how things stand.  He is an outstanding doctor and an outstanding person.  It is a great pleasure to have him as my oncologist, and I’m especially pleased that he tolerates my questions and responds in ways that respect my intelligence.

Once again, as Alice Cooper sang,  “School’s out for the summer!”

April 25, 2013

Checking In


A couple of people have noted that I haven’t added a new post for a while, and they correctly assume it means that all is well.  Jana’s CML continues to respond to Gleevec, and my tumors have remained stable or perhaps even shrunk a little.

As of yesterday, I’ve had 12 pemetrexed infusions, one every three weeks, since late August.  I’ve had it so many times that I can almost predict my side effects to the hour they begin.  As I’ve noted before, the treatment is nothing like the cisplatin and pemetrexed regimen I had in Temple, but it’s getting old.  I feel the need for a break to let my body recover some strength, so I’m going to discuss it with my oncologist in three weeks.  I had a four month break last summer with no apparent problems, so I hope it works out a well this year.

I really didn’t have anything to say in this post, but I thought I ought to add a note.  Thanks for checking Cancer Couple from time to time.

January 2, 2013

Latest CT Scan Results

I generally get a CT scan after the third in a series of infusions. After receiving seven infusions beginning in December 2011, I had a four month break over the summer, and my last infusion (before the one I got today) was the sixth since I restarted chemotherapy in late August, so I had a CT scan last Friday.

I haven't seen a copy of the radiologist's report yet, but my oncologist said that the trend toward smaller tumor size continued. Given my background in educational assessment, I am leery of the reliability of small changes from CT to CT given the many sources of error inherent in the CT process, but I am encouraged by two successive CTs showing positive results. At the very worst, my mesothelioma is stable.

Consequently, I had another infusion this afternoon. This will be an interesting one to experience because my last infusion produced almost no sense of unwellness, and almost no fatigue which was very unusual. I'm not sure what happened last time, but it may be the result of my taking my anti-nausea medicine for only two days instead of my typical habit of taking it for three or four days. The prescription says to take the medicine as needed. How do you interpret that? Having a great dislike of vomiting, I had decided long ago to take it regularly until I was sure I was not going to become nauseated. However, last round I went online and looked up information on the drug, ondansetron, and found that it was only given for a short duration in the studies that demonstrated its effectiveness. I also learned that it slows down the movement of food through the body and promotes constipation, so I decided to take it only on the day of the infusion and on the next day. The result was that I had no nausea, and I believe I have been taking it for too many days in the past. Whether stopping the drug contributed to the relief of my sense of abdominal unwellness and chemo fatigue, is uncertain, but I'm not going to take it after tomorrow and see how I feel this time.

As I'm sure I've reported before, my chemo drug, pemetrexed, is reasonably well tolerated, and I want to continue taking it (with perhaps another summer break) as long as my cancer remains indolent.

December 17, 2012

Thanksgiving 2012

Thanksgiving Day is the day set aside to attend to the things we appreciate in our lives; however, normally for me it is just a day to get together with family and/or friends, to visit, and to share a special meal. This Thanksgiving meal was different, however, and made me really appreciate the time with family and friends.

We were joined at our table this year by a woman and her daughter and son-in-law who lost their husband/dad to malignant melanoma last April. When I was first diagnosed with mesothelioma in 2010, I reviewed the survival data and thought I had no more than a year to live. Subsequently, I believed that I probably had a rolling six-month life expectancy because the doctors would not give an estimate of how long I might live. Over the intervening two and a half years I have come to expect a longer life span and have begun to take it for granted; however, having these guests at our table made especially appreciative of the meal because their husband/father was unable to be with his family for the day, and he will never know his grandson who will be born next May.

Reflecting on these sad facts made me appreciate my doctors at Scott and White and the University of Colorado hospital—Doctors Smythe and Reznik who did a tremendous job of removing my original tumors, Dr. Gowan who got me started on chemotherapy, and Doctors Camidge and Weickhardt who have stayed on top of my case for the past year and a half in Denver. I also greatly appreciate the many highly professional, compassionate, upbeat, and kind nurses at both hospitals who have given me tremendous respect for these often undervalued caregivers. In fact, everyone I’ve met at these two hospitals deserves praise for their competence and professionalism.

Obviously, I am extremely thankful for he support of Jana, our daughters and their families, and my mother-in-law. But I’m perhaps most thankful for the fact that the girls have given us grandchildren. Here’s why. There is no real difference between the mind and the body, but it is a useful fiction to think as if there is. I believe the mental stress of my latter years in DoDDS and my retirement played a role in the development of my mesothelioma. It might have eventually developed, but I believe stress probably facilitated the transformation of those asbestos-tainted cells into mesothelioma.

Jana’s and my diagnoses and my subsequent treatment have certainly been stressful and might have hastened the further development of my disease, but the stresses may not be as great as one might expect. I have never viewed my disease as a tragedy, a great disappointment, yes, but not a tragedy. The reason is that by that point in my life I had accomplished what I saw as the major responsibilities of a husband and father—our daughters were grown and had a good education, they were married to outstanding young men, and Jana and I had sufficient financial resources to expect to live a reasonably comfortable life for many years. So while it is a tragedy when a child or young adult has an incurable cancer, it is not so stressful when ones life is in good order and nearing an end anyway.

So while our cancers have been stressful, the conditions of our lives have offset that stress at least so some degree and, I believe, contributed to a longer life span than I had expected. However, there is one other factor that I believe has contributed even more to my life span, and that is grandchildren. The stress-reducing peace and joy my grandchildren bring to my life must be therapeutic. They provide an enhanced motivation to live, so whatever good the doctors and nurses have done for my body, I believe Jamie and Madeline have done equally as much or more good for my health. At some time in the indeterminate future, I will slip away, but until that time, I believe my love for them and the joy I have in seeing them will work to prolong my life. For that I am extremely grateful and at the same time saddened that our guests’ husband/father did not get to know his future grandchildren and benefit from the support they unwittingly provide.